4.8 Article

Clonal populations of a human TNBC model display significant functional heterogeneity and divergent growth dynamics in distinct contexts

期刊

ONCOGENE
卷 41, 期 1, 页码 112-124

出版社

SPRINGERNATURE
DOI: 10.1038/s41388-021-02075-y

关键词

-

资金

  1. NIH [PPG P01CA080111]
  2. Breast Cancer Research Foundation [BCRF-19-021]
  3. Ludwig Center at Harvard

向作者/读者索取更多资源

Intratumoral heterogeneity exists in different tumor types and models, affecting tumor progression and drug resistance. In this study, subclonal populations derived from a triple-negative breast cancer cell line showed unique genetic alterations and varied in growth and tumor forming ability. Clonal dynamics analysis revealed selection for distinct populations in different environments, with one subclone showing selective advantage and decreased sensitivity to interferon signaling in xenograft tumors, suggesting potential implications for cancer and xenograft models.
Intratumoral heterogeneity has been described for various tumor types and models of human cancer, and can have profound effects on tumor progression and drug resistance. This study describes an in-depth analysis of molecular and functional heterogeneity among subclonal populations (SCPs) derived from a single triple-negative breast cancer cell line, including copy number analysis, whole-exome and RNA sequencing, proteome analysis, and barcode analysis of clonal dynamics, as well as functional assays. The SCPs were found to have multiple unique genetic alterations and displayed significant variation in anchorage independent growth and tumor forming ability. Analyses of clonal dynamics in SCP mixtures using DNA barcode technology revealed selection for distinct clonal populations in different in vitro and in vivo environmental contexts, demonstrating that in vitro propagation of cancer cell lines using different culture conditions can contribute to the establishment of unique strains. These analyses also revealed strong enrichment of a single SCP during the development of xenograft tumors in immune-compromised mice. This SCP displayed attenuated interferon signaling in vivo and reduced sensitivity to the antiproliferative effects of type I interferons. Reduction in interferon signaling was found to provide a selective advantage within the xenograft microenvironment specifically. In concordance with the previously described role of interferon signaling as tumor suppressor, these findings suggest that similar selective pressures may be operative in human cancer and patient-derived xenograft models.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据